An amended ownership statement filed on November 19, 2026 by Rajat Raheja, an officer of Amdocs Limited (NASDAQ:DOX), reported a series of restricted stock unit vestings and same-day share sales between November 10 and November 15, 2026, and corrected an error in a prior filing regarding derivative securities owned.
Key Highlights
- Multiple RSU vestings: Raheja received ordinary shares through code-M transactions on November 10, 11, 14, and 15, 2026, covering grants from several separate RSU award tranches.
- Shares sold at two price points: Sales of 374 and 746 shares on November 10 were executed at $42.18 per share; subsequent sales on November 14 and 15 were executed at $43.34 per share.
- November 11 sale at $43.14: 360 ordinary shares were sold at $43.14 per share following a same-day vesting.
- Performance Stock Unit grant certified: A grant of Performance Stock Units originally made on November 14, 2025 had its performance certified on November 3, 2026, with 2,340 units subject to vesting in substantially equal installments on November 14, 2026, November 14, 2027, and November 14, 2028.
- Prior filing corrected: A November 13, 2026 filing had inadvertently reported 5,503 derivative securities beneficially owned following an RSU vesting; the amended filing states the correct figure was 0.
- Resulting direct ownership: Following all reported transactions, Raheja held 0 ordinary shares directly in each line item where shares were acquired and immediately sold.
RSU Vestings, Share Sales, and a Corrected Derivative Count for Amdocs Officer Raheja
According to the amended filing, Rajat Raheja, an officer at Amdocs Limited, a global provider of software and services primarily for communications and media companies, exercised restricted stock units converting to ordinary shares on four separate dates in November 2026. Each vesting was immediately followed by a sale of the same number of shares, resulting in a net direct holding of zero ordinary shares after each transaction pair.
The filing discloses that on November 10, 2026, two separate RSU tranches vested: 374 shares from one award, of which 374 additional shares remain scheduled to vest on November 10, 2027, and 746 shares from a second award that vested in full. Both sets of shares were sold at $42.18. On November 11, 2026, a further 360 shares vested in full and were sold at $43.14. On November 14 and 15, 2026, additional tranches vested in connection with both time-based RSU awards and the certified Performance Stock Unit grant, with sales occurring at $43.34 per share on November 14 and 15.
The amendment also addresses a specific correction: the filing states that a November 13, 2026 Form 4 "inadvertently reported that, following the vesting of these RSUs, the number of derivative securities beneficially owned following the transaction was 5,503," and that "in fact... the number of derivative securities beneficially owned following the transaction was 0." Remaining unvested RSU and PSU tranches are scheduled across dates in 2027, 2028, and 2029 as detailed in the filing's explanatory footnotes.
What Was Disclosed
The amended filing by Amdocs officer Rajat Raheja covered RSU vestings and same-day share sales between November 10 and November 15, 2026, prices ranging from $42.18 to $43.34, and a correction to derivative securities ownership reported in a prior filing.




Please wait processing your request...